The report will be delivered in 2-3 business days.

Drugs for Immunotherapy Global Market Report 2020

Drugs for Immunotherapy
Purchase Options
Request Sample
Request For Discount
FAQ

Starting Price : $ 4000.00 | Pages : 200 | Published : January 2020 | SKU CODE : 7187 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The drugs for immunotherapy market consists of sales of immunotherapy drugs. Immunotherapy drugs help the immune system to fight cancer by stimulating the immune system of the body and generate an immune response aiding the production of antibodies.

The global drugs for immunotherapy market was valued at about $134.95 billion in 2018 and is expected to grow to $222.3 billion at a CAGR of 13.3% through 2022.

The immunotherapy drugs market is being driven by rising incidences of cancer globally. The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to the World Health Organization, cancer is responsible for an estimated 9.6 million deaths in 2018. The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040. The rising incidences of cancer are expected to increase the demand for immunotherapy drugs driving market growth.

The high cost of immunotherapy drugs is acting as a restraint on the drugs for immunotherapy market as less number of patients can afford the treatment. Immunotherapy drugs are expensive as drugs are made specifically for each patient and investment costs in the research and development are high. For instance, Novartis’ Kymriah and Gilead Sciences’ Yescarta are two immunotherapy treatments that cost between $373,000 and $475,000 per patient depending on the type of cancer. The Yervoy (ipilimumab) drug from Bristol-Myers Squibb, for the treatment of melanoma, a type of skin cancer costs $120,000 per course of treatment. The high cost of immunotherapy drugs make it unaffordable, thereby affecting market growth.

Manufacturers of immunotherapy drugs are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business. For example, in April 2018, Illumina Inc. and Bristol-Myers Squibb (BMS) collaborated to utilize Illumina’s next-generation sequencing (NGS) technology to develop and commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb's oncology portfolio. In April 2018, Allogene Therapeutics Inc. and Pfizer Inc. entered into an asset contribution agreement to use Pfizer’s portfolio of assets related to allogeneic CAR-T therapy.

Manufacturers of immunotherapy drugs are governed by various regulatory bodies such as the Food and Drug Administration in the USA. The Food and Drug Administration (FDA) regulates drugs and biologics under the authority granted to it by the Federal Food, Drug, and Cosmetic Act (FD&C Act, 1938) and its amendments. Under this authority, FDA regulates the pre-market testing and marketing approval for all immunotherapeutic agents, either as drugs or biologics depending on the source and function of the investigational agent. Immunotherapeutic products that are regulated as biologics include antibodies and proteins and some nucleic acids.

In September 2018, Roche acquired cancer immunotherapy developer Tusk Therapeutics for $759 million.Tusk Therapeutics Ltd develops immuno-oncology treatments for the development of therapeutic antibodies. Tusk Therapeutics Ltd was founded in 2014 and is headquarter at Stevenage, United Kingdom.

Major players in the market are F. Hoffmann-La Roche Ltd, Novartis AG, Amgen, Inc., AbbVie, Inc., Merck & Co., Inc.

    1. Executive Summary

    2. Drugs for Immunotherapy  Market Characteristics

    3. Drugs for Immunotherapy  Market Size And Growth

    3.1. Global Drugs for Immunotherapy  Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Drugs for Immunotherapy  Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Drugs for Immunotherapy  Market Segmentation

    4.1. Global Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Monoclonal antibodies

    Interferons

    Interleukins

    Vaccines

    Checkpoint Inhibitors

    Others

    4.2. Global Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Cancer

    Autoimmune & Inflammatory Diseases

    Infectious Diseases

    Others

    4.3. Global Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals & Clinics

    Ambulatory Surgical Centers

    Others

    5. Drugs for Immunotherapy  Market Regional And Country Analysis

    5.1. Global Drugs for Immunotherapy  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Drugs for Immunotherapy  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Drugs for Immunotherapy  Market  

    6.1. Asia-Pacific Drugs for Immunotherapy  Market Overview  

    6.2. Asia-Pacific Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Drugs for Immunotherapy  Market  

    7.1. China Drugs for Immunotherapy  Market Overview  

    7.2. China Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Drugs for Immunotherapy  Market  

    8.1. India Drugs for Immunotherapy  Market Overview  

    8.2. India Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Drugs for Immunotherapy  Market  

    9.1. Japan Drugs for Immunotherapy  Market Overview  

    9.2. Japan Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Drugs for Immunotherapy  Market  

    10.1. Australia Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Drugs for Immunotherapy  Market  

    11.1. Indonesia Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Drugs for Immunotherapy  Market  

    12.1. South Korea Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Drugs for Immunotherapy  Market  

    13.1. Western Europe Drugs for Immunotherapy  Market Overview

    13.2. Western Europe Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Drugs for Immunotherapy  Market  

    14.1. UK Drugs for Immunotherapy  Market Overview

    14.2. UK Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Drugs for Immunotherapy  Market  

    15.1. Germany Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Drugs for Immunotherapy  Market  

    16.5. France Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Drugs for Immunotherapy  Market  

    17.1. Eastern Europe Drugs for Immunotherapy  Market Overview

    17.2. Eastern Europe Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Drugs for Immunotherapy  Market  

    18.1. Russia Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Drugs for Immunotherapy  Market  

    19.1. North America Drugs for Immunotherapy  Market Overview

    19.2. North America Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Drugs for Immunotherapy  Market  

    20.1. USA Drugs for Immunotherapy  Market Overview

    20.2. USA Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Drugs for Immunotherapy  Market  

    21.1. South America Drugs for Immunotherapy  Market Overview

    21.2. South America Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Drugs for Immunotherapy  Market  

    22.1. Brazil Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Drugs for Immunotherapy  Market  

    23.1. Middle East Drugs for Immunotherapy  Market Overview

    23.2. Middle East Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Drugs for Immunotherapy  Market  

    24.1. Africa Drugs for Immunotherapy  Market Overview

    24.2. Africa Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Drugs for Immunotherapy  Market Competitive Landscape And Company Profiles

    25.1. Drugs for Immunotherapy  Market Competitive Landscape

    25.2. Drugs for Immunotherapy  Market Company Profiles

    25.2.1. F. Hoffmann-La Roche Ltd

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Novartis AG

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Amgen, Inc

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. AbbVie, Inc

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Merck & Co., Inc

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Drugs for Immunotherapy  Market

    27. Drugs for Immunotherapy  Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Drugs for Immunotherapy  Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Drugs for Immunotherapy  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Drugs for Immunotherapy  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Australia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Indonesia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: South Korea, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Western Europe, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: UK, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: UK, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Germany, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: France, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: France, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Russia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: North America, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: North America, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: USA, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: USA, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: South America, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: South America, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: Brazil, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Middle East, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Africa, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 66: Novartis AG Financial Performance
  • Table 67: Amgen, Inc Financial Performance
  • Table 68: AbbVie, Inc Financial Performance
  • Table 69: Merck & Co., Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Drugs for Immunotherapy  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Drugs for Immunotherapy  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Australia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: South Korea, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: UK, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Germany, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: France, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: France, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Russia, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: North America, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: USA, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: South America, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: Brazil, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Middle East, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Africa, Drugs for Immunotherapy  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Drugs for Immunotherapy  Market, Segmentation By Therapy Area, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Drugs for Immunotherapy  Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 66: Novartis AG Financial Performance
  • Figure 67: Amgen, Inc Financial Performance
  • Figure 68: AbbVie, Inc Financial Performance
  • Figure 69: Merck & Co., Inc Financial Performance
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
Read More
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Read More
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Read More
Developments in Drug Discovery Procedures Will Aid Market Growth For Diabetes Therapies
Read More
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Read More
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Read More
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Read More
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2021
View Report
Cardiovascular Drugs Global Market Report 2020
View Report
Dermatology Drugs Global Market Report 2020
View Report
Gastrointestinal Drugs Global Market Report 2020
View Report
Hematology Drugs Global Market Report 2020
View Report
Metabolic Disorders Drugs Global Market Report 2020
View Report
Musculoskeletal Disorders Drugs Global Market Report 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)